CMV infection
It is common that infections such as cytomegalovirus (CMV) are passed on with the donated organ. This infection is often fairly straightforward to diagnose, treat and monitor.
More than half of healthy people will have been exposed to CMV (similar to the shingles virus). After the initial infection it remains dormant in the body. Sometimes the CMV does not come from the donor organ but is dormant within the transplant patient, becoming active after the transplant as a result of the patient’s weakened immune system.
CMV infection causes fevers, fatigue and diarrhoea with low white cell-count (neutropenia) and/or abnormal liver tests. If you develop CMV infection, you will be treated with antiviral medication either orally or intravenously. If you are at increased risk of CMV infection you will receive preventative (prophylactic) treatment with a medication such as valganciclovir.
EBV infection
Sometimes, the Epstein-Barr virus (EBV) can be passed on with the transplanted bowel. EBV causes glandular fever, which is common in young people. The virus can lie dormant within cells inside the bowel transplant. With immune-suppression, the virus can reactivate. In some transplant patients this can cause problems that are similar to glandular fever (swollen glands in the neck and armpit and groin, fevers, feeling unwell).
Sometimes, lymph node cancers can occur with EBV infections (post-transplant lymphoproliferative disorders – PTLD). PTLD can occur in about 15 in 100 people after a bowel transplant. These are serious illnesses and require specialist treatment. PTLD can usually be successfully treated with a medication called rituximab.